These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31262710)

  • 1. Sphingomyelin synthase 1 enhances BCR signaling to promote lupus-like autoimmune response.
    Wang C; Ming B; Wu X; Wu T; Cai S; Hu P; Tang J; Tan Z; Liu C; Zhong J; Zheng F; Dong L
    EBioMedicine; 2019 Jul; 45():578-587. PubMed ID: 31262710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly IC pretreatment suppresses B cell-mediated lupus-like autoimmunity through induction of Peli1.
    Wang Y; Yuan J; Dai D; Liu J; Xu J; Miao X; Wang H; Mao C; Xiao Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):862-868. PubMed ID: 30032173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies.
    Peterson JN; Boackle SA; Taitano SH; Sang A; Lang J; Kelly M; Rahkola JT; Miranda AM; Sheridan RM; Thurman JM; Rao VK; Torres RM; Pelanda R
    Front Immunol; 2022; 13():795209. PubMed ID: 35185888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.
    Jones SA; Toh AE; Odobasic D; Oudin MA; Cheng Q; Lee JP; White SJ; Russ BE; Infantino S; Light A; Tarlinton DM; Harris J; Morand EF
    Ann Rheum Dis; 2016 Apr; 75(4):739-47. PubMed ID: 26612340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production.
    Zhang M; Yao C; Cai J; Liu S; Liu XN; Chen Y; Wang S; Ji P; Pan M; Kang Z; Wang Y
    J Transl Med; 2019 Jan; 17(1):37. PubMed ID: 30670047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation.
    Matsumoto G; Hashizume C; Watanabe K; Taniguchi M; Okazaki T
    Mol Med; 2019 Dec; 25(1):56. PubMed ID: 31847800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
    Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
    Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMS2 deficiency impairs PKCδ-regulated B cell tolerance in the germinal center.
    Ou P; Stanek A; Huan Z; Roman CAJ; Huan C
    Cell Rep; 2021 Aug; 36(9):109624. PubMed ID: 34469734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity.
    Stohl W; Jacob N; Quinn WJ; Cancro MP; Gao H; Putterman C; Gao X; Pricop L; Koss MN
    J Immunol; 2008 Jul; 181(1):833-41. PubMed ID: 18566449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
    Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
    Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity.
    Stohl W; Jacob N; Guo S; Morel L
    Arthritis Rheum; 2010 Aug; 62(8):2432-42. PubMed ID: 20506216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-21 deficiency protects from lupus-like autoimmunity in the chronic graft-versus-host disease model of systemic lupus erythematosus.
    Garchow B; Kiriakidou M
    Clin Immunol; 2016 Jan; 162():100-6. PubMed ID: 26631756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice.
    Zhou Y; Chen H; Liu L; Yu X; Sukhova GK; Yang M; Zhang L; Kyttaris VC; Tsokos GC; Stillman IE; Ichimura T; Bonventre JV; Libby P; Shi GP
    J Immunol; 2017 Apr; 198(7):2568-2577. PubMed ID: 28219888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
    Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
    J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell maturation antigen deficiency exacerbates lymphoproliferation and autoimmunity in murine lupus.
    Jiang C; Loo WM; Greenley EJ; Tung KS; Erickson LD
    J Immunol; 2011 Jun; 186(11):6136-47. PubMed ID: 21536804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
    Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
    Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of T cells in Act1-deficient mice results in elevated IgM-specific autoantibodies but reduced lupus-like disease.
    Johnson AC; Davison LM; Giltiay NV; Vareechon C; Li X; Jørgensen TN
    Eur J Immunol; 2012 Jul; 42(7):1695-705. PubMed ID: 22585710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
    Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
    Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice.
    Li Z; Fan Y; Liu J; Li Y; Huan C; Bui HH; Kuo MS; Park TS; Cao G; Jiang XC
    Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1577-84. PubMed ID: 22580896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.